Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: December 30, 2020
Reporting Period: The filing addresses events occurring between December 2, 2020, and December 30, 2020.
Key Financial Metrics
This filing is a Regulation FD disclosure regarding a regulatory inquiry and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material event disclosed is the initiation of a non-public, fact-finding inquiry by the U.S. Securities and Exchange Commission (SEC). This inquiry commenced on December 15, 2020, as an informal review triggered by a research report published by Culper Research on December 2, 2020.
Outlook, Risks, and Management Commentary
- SEC Inquiry: The Company is cooperating fully with the SEC inquiry. Management expects to satisfy the SEC regarding the appropriateness of its accounting policies and refute the claims made in the Culper report.
- Allegations: The Culper report made disparaging claims regarding the Company's accounting policies, specifically alleging inaccuracies in revenue recognition. Management asserts these claims are false, misleading, and intended to negatively impact the stock price to support short sellers.
- Defense: The Company states its revenue recognition method is fully described in audited financial statements, consistent with GAAP, and aligned with peer methodologies.
- Risks: Forward-looking statements are subject to risks including the impact of the COVID-19 pandemic on product demand and operational challenges.
Investor Verification Checklist
- Verify the status of the SEC informal review and any subsequent communications from the Commission.
- Review the Company's audited financial statements to confirm revenue recognition policies as described in the filing.
- Monitor stock price volatility and trading volume related to the short-seller allegations.
- Check for any future 8-K filings or press releases regarding the resolution of the inquiry.